查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631156

植入周围炎市场规模、份额、趋势分析报告：按方法类型、地区、细分市场预测，2025-2030 年

Peri-implantitis Market Size, Share & Trends Analysis Report By Method Type (Surgical (Bone Regeneration, Open Flap Debridement, Implantoplasty), Non-surgical (Laser Debridement)), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

植体植入炎市场成长与趋势

根据 Grand View Research, Inc. 的最新报告，全球植体周围植入市场规模预计在 2025 年至 2030 年间以 9.1% 的复合年增长率增长，到 2030 年达到 17.5 亿美元。

植体周围植入是一种部位特异性破坏性发炎性疾病，影响骨整合植入周围的软组织和硬组织，导致骨质流失和植入袋的形成。据报道，10 年内人工植牙的成功率为 92% 至 98%。然而，患有牙周炎病史的患者数量不断增加、与有效治疗植体周围植入相关的技术进步的出现以及吸烟和糖尿病患者数量不断增加等因素正在推动市场增长。

随着全球植入的植入数量的增加，植体植入併发症的发生率预计也会增加。根据 NCBI 的数据，1999 年至 2017 年间，美国的植入普及率每年增长率为 14.0%。英国每年约有 26 万颗植入进行植入，这表明对人工植牙的需求正在增长。随着植入成为常见的治疗方法，植入黏膜炎、植体植入相关疾病的盛行率呈现正相关性。此外，根据疾病预防控制中心的数据，2019 年美国30 岁成年人中 47.2% 患有某种形式的牙周疾病。男性患有这种疾病的几率比女性更高，因为男性更容易受到吸烟和糖尿病等健康问题的影响。雷射清创、引导骨再生 (GBR) 和诊断遗传生物标记技术等技术的进步预计将推动植入炎治疗市场的成长。

Peri -植体炎市场报告重点

  • 2024 年，外科手术领域占据了市场主导地位，因为外科清创手术效率高，且被认为是治疗植体周围植入最有效的技术。
  • 预计非手术技术雷射清创将在预测期内实现最高成长，因为它能够有效地选择性去除结石并带来更好的临床效果。
  • 由于植体周围植入治疗技术的不断进步，欧洲将在 2024 年占据市场主导地位。
  • 由于人口老化加剧、人们对植入和相关疾病的认识不断提高以及技术的快速进步，预计亚太地区将在预测期内实现最高的复合年增长率。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章植入周围炎市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章 植体植入炎市场：依方法类型、业务分析

  • 2024 年和 2030 年方法类型市场占有率
  • 方法类型细分仪表板
  • 2018 年至 2030 年按方法类型分類的市场规模、预测与趋势分析
  • 外科
  • 非手术

第 5 章 植体植入炎市场：区域、估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 按国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Pfizer Inc.
    • Cadila Pharmaceuticals
    • GaronitPharma
    • Basic Pharma Life Science Pvt Ltd.
    • Prachi Pharmaceuticals Private Limited.
    • Geistlich Pharma India Pvt. Ltd.
    • Healthy Life Pharma Private Limited.
    • Zimmer Biomet.
    • Institut Straumann AG
    • Dentsply Sirona
Product Code: GVR-4-68039-099-7

Peri-implantitis Market Growth & Trends:

The global peri-implantitis market size is expected to reach USD 1.75 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%-98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.

The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.

Peri-implantitis Market Report Highlights:

  • The surgical segment dominated the market in 2024 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
  • Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
  • Europe dominated the market in 2024 owing to the rising technological advancements for peri-implantitis treatment
  • In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Method Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Peri-implantitis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Peri-implantitis Market: Method Type Business Analysis

  • 4.1. Method Type Market Share, 2024 & 2030
  • 4.2. Method Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Method Type, 2018 to 2030 (USD Billion)
  • 4.4. Surgical
    • 4.4.1. Surgical Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Bone Regeneration
      • 4.4.2.1. Bone Regeneration Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Open Flap Debridement
      • 4.4.3.1. Open Flap Debridement Market, 2018 - 2030 (USD Billion)
    • 4.4.4. Implantoplasty
      • 4.4.4.1. Implantoplasty Market, 2018 - 2030 (USD Billion)
  • 4.5. Non-surgical
    • 4.5.1. Non-surgical Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Mechanical Debridement
      • 4.5.2.1. Mechanical Debridement Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Laser Debridement
      • 4.5.3.1. Laser Debridement Market, 2018 - 2030 (USD Billion)
    • 4.5.4. Antibiotics
      • 4.5.4.1. Antibiotics Market, 2018 - 2030 (USD Billion)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Peri-implantitis Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Europe
    • 5.5.1. Europe Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Latin America
    • 5.7.1. Latin America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. MEA
    • 5.8.1. MEA Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Pfizer Inc.
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Method Type Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Cadila Pharmaceuticals
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Method Type Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. GaronitPharma
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Method Type Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Basic Pharma Life Science Pvt Ltd.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Method Type Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. Prachi Pharmaceuticals Private Limited.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Method Type Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. Geistlich Pharma India Pvt. Ltd.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Method Type Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. Healthy Life Pharma Private Limited.
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Method Type Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. Zimmer Biomet.
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Method Type Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. Institut Straumann AG
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Method Type Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. Dentsply Sirona
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Method Type Benchmarking
      • 6.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global peri-implantitis market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 5 North America peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 6 North America peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 7 U.S. peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 8 Canada peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 9 Mexico peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 10 Europe peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 11 Europe peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 12 UK peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 13 Germany peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 14 France peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 15 Italy peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 16 Spain peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 17 Norway peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 18 Denmark peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 19 Sweden peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 20 Asia Pacific peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 21 Asia Pacific peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 22 Japan peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 23 China peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 24 India peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 25 Australia peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 26 South Korea peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 27 Thailand peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 28 Latin America peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 29 Latin America peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 30 Brazil peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 31 Argentina peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 32 Middle East & Africa peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 33 Middle East & Africa peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 34 South Africa peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 35 Saudi Arabia peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 36 UAE peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 37 Kuwait peri-implantitis market, by method type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Peri-implantitis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Method type outlook (USD Billion)
  • Fig. 10 Transportation mode outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Peri-implantitis market dynamics
  • Fig. 13 Peri-implantitis market: Porter's five forces analysis
  • Fig. 14 Peri-implantitis market: PESTLE analysis
  • Fig. 15 Peri-implantitis market: Method type segment dashboard
  • Fig. 16 Peri-implantitis market: Method type market share analysis, 2024 & 2030
  • Fig. 17 Surgical market, 2018 - 2030 (USD Billion)
  • Fig. 18 Bone regeneration market, 2018 - 2030 (USD Billion)
  • Fig. 19 Open flap debridement market, 2018 - 2030 (USD Billion)
  • Fig. 20 Implantoplasty market, 2018 - 2030 (USD Billion)
  • Fig. 21 Non-surgical market, 2018 - 2030 (USD Billion)
  • Fig. 22 Mechanical debridement market, 2018 - 2030 (USD Billion)
  • Fig. 23 Laser debridement market, 2018 - 2030 (USD Billion)
  • Fig. 24 Antibiotics market, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market, 2018 - 2030 (USD Billion)
  • Fig. 26 Peri-implantitis market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 35 Europe peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 40 France country dynamics
  • Fig. 41 France peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 55 China country dynamics
  • Fig. 56 China peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 57 India country dynamics
  • Fig. 58 India peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 65 Latin America peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 70 MEA peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework